Gut Feeling: Understanding the Mechanisms Underlying the Antidepressant Properties of Probiotics
Gut Feeling: Understanding the Mechanisms Underlying the Antidepressant Properties of Probiotics
Previous research has suggested that probiotics can improve depressive symptoms in patients with Major Depressive Disorder (MDD), particularly when used in addition to antidepressants. The aim of this exploratory pilot study is to improve the investigator's understanding of the mechanisms underlying these effects. This study will assess the effects of an 8-week double-blind placebo-controlled probiotic intervention on the gut microbiome, inflammatory marker levels, brain activity and neurotransmitter levels in patients with MDD and their relationship to changes in mood. This study will also recruit a group of demographically-matched healthy controls for gut microbiome comparison with the MDD group (non-interventional).
Inclusion criteria for MDD participants:
Exclusion criteria for MDD participants:
Inclusion criteria for Healthy Volunteers: